Title:
NUCLEOSIDE DRUG FOR TREATING OR PREVENTING CORONAVIRUS INFECTION, AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2023/207942
Kind Code:
A1
Abstract:
The present invention relates to the technical field of medicines, and in particular to a nucleoside drug for treating or preventing coronavirus infection, and a use thereof. The present invention further relates to a method for preparing a prodrug of a nucleoside drug. Compared with other nucleoside drugs such as remdesivir for injection, the nucleoside drug of formula (I) or formula (II) provided in the present invention is more suitable for oral administration to individuals in need.
Inventors:
LI XIAOLIN (CN)
QI LONGWU (US)
XU SHUSEN (CN)
DU NANA (CN)
QI LONGWU (US)
XU SHUSEN (CN)
DU NANA (CN)
Application Number:
PCT/CN2023/090488
Publication Date:
November 02, 2023
Filing Date:
April 25, 2023
Export Citation:
Assignee:
MIRACURE BIOTECHNOLOGY LTD (CN)
International Classes:
C07F9/6561; A61K31/675; A61P31/14; A61P31/16
Domestic Patent References:
| WO2021167882A1 | 2021-08-26 |
Foreign References:
| CN112778310A | 2021-05-11 | |||
| CN110869028A | 2020-03-06 | |||
| CN110724174A | 2020-01-24 | |||
| CN113354684A | 2021-09-07 | |||
| CN113368251A | 2021-09-10 | |||
| CN103108876A | 2013-05-15 | |||
| CN102015714A | 2011-04-13 |
Attorney, Agent or Firm:
BEIJING ORIGINTELLIGENCE IP LAW FIRM (CN)
Download PDF: